QIAGEN - QuantiFERON-TB Gold Plus

Inmates and staff in correctional facilities are at an increased risk for TB infection. The best way to prevent TB transmission in these facilities is to identify latent TB infection (LTBI) and treat it before it poses a threat.

Learn more about the threat of TB and the best testing options for correctional facilities:

On-demand webinar: combating the threat of TB through modern control methods

Correctional facilities play a critical role in controlling TB. Join Dr. Masae Kawamura as she discusses recent policy advancements that are helping prevent tuberculosis in jails and prisons. You'll learn about the latest diagnostic tools for TB infection as well as new preventative treatment regimens that are increasing compliance and decreasing cost.

In this recorded webinar, Dr. Kawamura answers top questions from your colleagues, such as how IGRA testing can help mitigate the current skin test (TST/PPD) shortage. Through case studies and publications, you'll learn why the CDC recommends modern TB blood tests and how they can streamline testing at your facility.

Dr. Masae Kawamura is a former TB Controller and current Senior Director of Scientific and Medical Affairs for TB diagnostics at QIAGEN.

First Name*

Last Name*

Email Address*

City*

Country*

State or Province

Zip or Postal Code*

Organization*

Job Profession*

Phone*

What test do you most often use as part of your clinical assessment for diagnosis of LTBI?*

Interferon-gamma release assay (IGRA): QuantiFERON®-TB Gold (Plus)

Interferon-gamma release assay (IGRA): T-SPOT®.TB

Tuberculin Skin Test (TST) / Mantoux

On average, how many TB tests does your practice perform a month?*

I want to be the first to hear about offers and news from QIAGEN.*

I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further special offers, contests and product information.

Thank you for submitting your request. We will get back to you shortly.

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to-date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.

Terms and Conditions: Subject to your consent given above, by clicking on "submit", QIAGEN may use your personal information for internal business and marketing purposes that may include regular promotional offers, news, invitations via email or telephone. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation All information you provide in this site will be governed by our Privacy Policy.

Overview

Fact sheet

On-demand webinar: combating the threat of TB through modern control methods

Thank you for submitting your request. We will get back to you shortly.